Comparison of home and hospital intravenous antibiotic therapy for clinical outcome in patients with a pulmonary exacerbation of cystic fibrosis. Do they always need to be admitted?

Autor:	Maeve P. Smith, Emad Saad, Imran Hassan, Winnie M. Leung, Josette Salgado, Neil E. Brown
Rok vydání:	2018
Předmět:	Pulmonary and Respiratory Medicine medicine.medical_specialty medicine.drug_class business.industry Antibiotics Critical Care and Intensive Care Medicine medicine.disease Intravenous antibiotic therapy Cystic fibrosis Internal medicine medicine In patient business Pulmonary exacerbation
Zdroj:	Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2:133-137
ISSN:	2474-5340 2474-5332
DOI:	10.1080/24745332.2018.1461037
Popis:	INTRODUCTION: Canadian Cystic Fibrosis (CF) patients spent over 24,900 days in hospital and underwent 867 home intravenous (IV) antibiotic treatments in 2014. CF pulmonary exacerbations are treated...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5dd739b18db06e25a1d2bb706c703da0 https://doi.org/10.1080/24745332.2018.1461037 Zobrazit plný text záznamu